SCHEMBL6963770

SCHEMBL6963770

Nc1nnc(SCCCCCCCl)s1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.70
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
MAPT P10636 2/20 0.47
LMNA P02545 2/20 0.47
HPGD P15428 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MAPK1 P28482 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TP53 P04637 1/20 0.46
HTT P42858 1/20 0.46
FBP1 P09467 1/20 0.45
GRIN2A Q12879 1/20 0.43
GRIN2B Q13224 1/20 0.43
GAA P10253 1/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10974071 0.96 ALDH1A1 (0.69) ALDH1A1MEN1KMT2ATDP1L3MBTL1
SCHEMBL30106089 0.85 ALDH1A1 (0.59) ALDH1A1MEN1KMT2ATDP1L3MBTL1
SCHEMBL16378590 0.82 ALDH1A1 (0.70) ALDH1A1MEN1KMT2ATDP1L3MBTL1
SCHEMBL9530535 0.82 ALDH1A1 (1.00) ALDH1A1MEN1KMT2ATDP1L3MBTL1
SCHEMBL4399146 0.82 ALDH1A1 (1.00) ALDH1A1MEN1KMT2ATDP1L3MBTL1
SCHEMBL10559488 0.82 ALDH1A1 (1.00) ALDH1A1MEN1KMT2ATDP1L3MBTL1
SCHEMBL15362563 0.80 ALDH1A1 (0.68) ALDH1A1MEN1KMT2ATDP1L3MBTL1
SCHEMBL11228856 0.79 ALDH1A1 (0.66) ALDH1A1MEN1KMT2ATDP1L3MBTL1
SCHEMBL2453384 0.77
SCHEMBL30106104 0.75 ALDH1A1 (0.60) ALDH1A1MEN1KMT2ATDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0768879-B1 THIADIAZOLE COMPOUNDS AS D3 DOPAMINE RECEPTOR LIGANDS BASF AG (DE) 2003-03-19 EP disclosed
US-5958923-A TREATMENT OF NERVOUS SYSTEM DISORDERS BASF AKTIENGESELLSCHAFT (DE) 1999-09-28 US disclosed
EP-0768879-A1 USE OF THIAZOLE AND THIADIAZOLE COMPOUNDS AS D3 DOPAMINE RECEPTOR LIGANDS BASF AKTIENGESELLSCHAFT (DE) 1997-04-23 EP disclosed
WO-1996002249-A1 USE OF THIAZOLE AND THIADIAZOLE COMPOUNDS AS D3 DOPAMINE RECEPTOR LIGANDS BASF AKTIENGESELLSCHAFT (DE) 1996-02-01 WO disclosed